M S Barrett

505 total citations
18 papers, 416 citations indexed

About

M S Barrett is a scholar working on Infectious Diseases, Molecular Medicine and Epidemiology. According to data from OpenAlex, M S Barrett has authored 18 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Molecular Medicine and 7 papers in Epidemiology. Recurrent topics in M S Barrett's work include Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). M S Barrett is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). M S Barrett collaborates with scholars based in United States. M S Barrett's co-authors include Ronald N. Jones, M E Erwin, Michael A. Pfaller, Franklin P. Koontz, Richard P. Wenzel, David M. Johnson, Martha J. Bale, R. Michael Massanari, D. S. Davenport and Christopher Flynn and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and American Journal of Infection Control.

In The Last Decade

M S Barrett

18 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M S Barrett United States 11 238 125 121 107 100 18 416
Toyoko Oguri Japan 15 349 1.5× 135 1.1× 229 1.9× 115 1.1× 143 1.4× 85 626
J Barnishan United States 11 143 0.6× 65 0.5× 114 0.9× 112 1.0× 80 0.8× 13 421
A Grossato Italy 9 254 1.1× 103 0.8× 83 0.7× 135 1.3× 100 1.0× 14 398
Sharon L. Hansen United States 12 255 1.1× 247 2.0× 120 1.0× 68 0.6× 76 0.8× 22 465
J.F. Lemeland France 10 128 0.5× 93 0.7× 106 0.9× 76 0.7× 51 0.5× 26 350
Sachiko Satake Japan 8 176 0.7× 113 0.9× 78 0.6× 110 1.0× 85 0.8× 17 391
C T Eliopoulos United States 8 272 1.1× 177 1.4× 171 1.4× 189 1.8× 75 0.8× 8 507
T.M.A. Weller United Kingdom 8 187 0.8× 126 1.0× 52 0.4× 82 0.8× 104 1.0× 11 320
Samuel Matsumura Canada 7 217 0.9× 167 1.3× 108 0.9× 63 0.6× 94 0.9× 9 345
Akio Kuga Japan 6 192 0.8× 101 0.8× 95 0.8× 245 2.3× 191 1.9× 10 456

Countries citing papers authored by M S Barrett

Since Specialization
Citations

This map shows the geographic impact of M S Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M S Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M S Barrett more than expected).

Fields of papers citing papers by M S Barrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M S Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M S Barrett. The network helps show where M S Barrett may publish in the future.

Co-authorship network of co-authors of M S Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of M S Barrett. A scholar is included among the top collaborators of M S Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M S Barrett. M S Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hayes, Jeffrey A. & M S Barrett. (2015). Bird fanciers lung in mushroom workers.. PubMed. 108(4). 119–20. 2 indexed citations
2.
Flynn, Christopher, et al.. (1997). Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates. Journal of Clinical Microbiology. 35(8). 2083–2086. 18 indexed citations
3.
Jones, Ronald N., M S Barrett, & M E Erwin. (1997). In vitro activity and spectrum of LY333328, a novel glycopeptide derivative. Antimicrobial Agents and Chemotherapy. 41(2). 488–493. 59 indexed citations
4.
5.
Barrett, M S, Ronald N. Jones, & M E Erwin. (1993). In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds. European Journal of Clinical Microbiology & Infectious Diseases. 12(2). 134–141. 6 indexed citations
6.
Barrett, M S, Ronald N. Jones, & M E Erwin. (1993). Ceftizoxime interpretive criteria for in vitro susceptibility tests with Neisseria gonorrhoeae. Journal of Clinical Microbiology. 31(9). 2531–2532. 1 indexed citations
7.
Barrett, M S & Ronald N. Jones. (1992). Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests withHaemophilus influenzae. European Journal of Clinical Microbiology & Infectious Diseases. 11(5). 462–465. 6 indexed citations
8.
Johnson, David M., et al.. (1992). Antimicrobial activity of ten macrolide, linsosamine and streptogramin drugs tested againstLegionella species. European Journal of Clinical Microbiology & Infectious Diseases. 11(8). 751–755. 36 indexed citations
9.
Erwin, M E, et al.. (1992). Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates. Antimicrobial Agents and Chemotherapy. 36(9). 2049–2050. 18 indexed citations
10.
Sanchez, Martha L., M S Barrett, & Ronald N. Jones. (1992). Use of the E test to predict high-level resistance to aminoglycosides among enterococci. Journal of Clinical Microbiology. 30(11). 3030–3032. 13 indexed citations
11.
12.
Erwin, M E, et al.. (1991). In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin. Antimicrobial Agents and Chemotherapy. 35(5). 929–937. 16 indexed citations
13.
Cabezudo, Ignacio, Michael A. Pfaller, M S Barrett, Martha J. Bale, & Richard P. Wenzel. (1990). In vitro comparison of mezlocillin and piperacillin plus tobramycin or gentamicin versus 100 gram-negative nosocomial bloodstream isolates. American Journal of Infection Control. 18(4). 250–256. 3 indexed citations
14.
Jones, Ronald N., M E Erwin, & M S Barrett. (1990). In vitro activity of clarithromycin (TE-031, A-67268) and 14OH-clarithromycin alone and in combination againstLegionella species. European Journal of Clinical Microbiology & Infectious Diseases. 9(11). 846–848. 12 indexed citations
15.
Pfaller, Michael A., et al.. (1990). Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. Journal of Clinical Microbiology. 28(9). 2064–2068. 138 indexed citations
16.
Pfaller, Michael A., M S Barrett, Franklin P. Koontz, et al.. (1989). Clinical evaluation of a direct fluorescent monoclonal antibody test for detection of Pseudomonas aeruginosa in blood cultures. Journal of Clinical Microbiology. 27(3). 558–560. 8 indexed citations
17.
Pfaller, Michael A., D. S. Davenport, Martha J. Bale, et al.. (1988). Development of the quantitative micro-test for slime production by coagulase-negative staphylococci. European Journal of Clinical Microbiology & Infectious Diseases. 7(1). 30–33. 42 indexed citations
18.
Barrett, M S, et al.. (1984). Bacterial meningitis in Johannesburg--1980-1982.. PubMed. 66(18). 677–9. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toyoko Oguri Breakdown of academic impact, for papers by J Barnishan Breakdown of academic impact, for papers by A Grossato Breakdown of academic impact, for papers by Sharon L. Hansen Breakdown of academic impact, for papers by J.F. Lemeland Breakdown of academic impact, for papers by Sachiko Satake Breakdown of academic impact, for papers by C T Eliopoulos Breakdown of academic impact, for papers by T.M.A. Weller Breakdown of academic impact, for papers by Samuel Matsumura Breakdown of academic impact, for papers by Akio Kuga
Rankless by CCL
2026